Datasets
Buyer room
TELEHEALTHTRUECOST.COMManage supplier listing
TelehealthTrueCost — Month-4 'true ongoing cost' telehealth pricing panel: for each major telehealth provider across three verticals (GLP-1 weight loss, women's HRT, men's TRT), the all-in monthly cost after introductory teaser pricing expires, decomposed into membership fee plus medication cost, with compounded-vs-branded medication flag, visit type, cancellation/refund terms, state-by-state availability, and regulatory/legal status notes (FDA warning letters, active litigation) — each figure carrying a named source and verification date.. Micro-scale but methodologically differentiated: a s…
supplier index read from their site
Month-4 'true ongoing cost' telehealth pricing panel: for each major telehealth provider across three verticals (GLP-1 weight loss, women's HRT, men's TRT), the all-in monthly cost after introductory teaser pricing expires, decomposed into membership fee plus medication cost, with compounded-vs-branded medication flag, visit type, cancellation/refund terms, state-by-state availability, and regulatory/legal status notes (FDA warning letters, active litigation) — each figure carrying a named source and verification date.
Asset class EquitiesTickers LLY · NVO · HIMSExchanges NYSE · NASDAQ
Sample, licence terms, pricing and eval results when TelehealthTrueCost publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about TelehealthTrueCost, answered from this page.
TelehealthTrueCost — Month-4 'true ongoing cost' telehealth pricing panel: for each major telehealth provider across three verticals (GLP-1 weight loss, women's HRT, men's TRT), the all-in monthly cost after introductory teaser pricing expires, decomposed into membership fee plus medication cost, with compounded-vs-branded medication flag, visit type, cancellation/refund terms, state-by-state availability, and regulatory/legal status notes (FDA warning letters, active litigation) — each figure carrying a named source and verification date.. Micro-scale but methodologically differentiated: a s…
TelehealthTrueCost offers (Alternative, Price) — Per vertical roughly 10-20 providers x 7 coded attributes with cost decomposition (~70-140 cells per vertical); across the GLP-1, HRT and TRT verticals plus a manufacturer-direct/insurance alternative box and ~5+ state availability pages, that is on the order of 300-600 sourced, dated observations per full refresh. The site states telehealth prices change monthly and that it tracks them, so a monthly cadence compounds this into a dated change-event series rather than a single snapshot..
True-ongoing-cost benchmarking that strips teaser pricing (the single hardest thing to get from provider pages directly); subscription-friction and churn-risk modelling via cancellation terms and month-4 cost step-ups; regulatory-risk scoring of compounded-medication programs using the FDA-warning-letter and litigation labels; state-level market-access modelling from the per-state availability layer; pricing-sustainability analysis of the cash-pay GLP-1/HRT/TRT categories; competitive monitoring for telehealth operators; input to payer and employer benefit design for cash-pay alternatives; NLP/agent evaluation data for extracting true recurring cost from promotional copy; event studies around medication launches (e.g. orforglipron FDA approval April 2026 and the July 2026 Medicare Part D $50 tier).
Coverage spans US; Health Care Facilities, Pharmaceuticals; alternative, price; equities.
TelehealthTrueCost has not added their own details yet. Not yet on file: